AcelRx Pharmaceuticals (ACRX) Financials

$1.13

$0.00 (0.24%)

As on 12-Mar-2024 09:30EDT

Market cap

$15 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	0.65	1.77	2.82	5.42	2.29	2.15
Cost of Revenue	--	2.59	3.75	6.03	6.81	3.98
Gross Profit	0.65	-0.82	-0.94	-0.62	-4.52	-1.83
Operating Expenses	17.54	30.87	35.03	40.35	49.69	33.90
Operating Profit (EBIT)	-16.89	-36.63	-35.97	-40.96	-54.21	-35.73
Other Income	--	--	--	3.89	3.50	-9.20
Profit before Tax	-10.29	47.77	-35.09	-40.38	-53.24	-47.15
Provision for Tax	--	0.01	0.01	0.00	0.00	0.00
Profit after Tax (Net Income)	-10.29	47.76	-35.10	-40.38	-53.24	-47.15
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	42.33	-35.10	-40.38	-53.24	-47.15

Liabilities ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	14.11	21.81	-35.89	-55.75	-41.42	4.25
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.78	11.90	95.28	104.41	119.16	100.35
Current Liabilities	4.51	13.77	18.51	17.64	13.61	15.93
Total Liabilities	20.40	47.49	77.89	66.30	91.36	120.53

Assets ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	8.84	22.92	22.40	19.47	19.67	12.54
Current Assets	11.56	24.57	55.49	46.83	71.69	107.99
Total Assets	20.40	47.49	77.89	66.30	91.36	120.53
Total Debt*	--	10.42	18.62	25.60	29.76	11.99
Net Current Assets	7.04	10.80	36.98	29.20	58.08	92.07

Cashflow ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	-17.49	-28.33	-30.00	-38.51	-51.18	-29.08
Cash Flow from Investing Activities	--	--	-26.12	34.14	-36.56	-10.88
Cash from Financing Activities	3.47	-0.51	41.51	16.96	14.45	75.03
Net Cash Inflow / Outflow	--	--	--	12.59	-73.29	35.07

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.61	6.45	-5.50	-8.75	-13.38	-13.35
Cash EPS ($)	-0.57	6.67	-5.19	-8.35	-12.96	-13.19
Adjusted Book Value ($)	0.83	2.95	--	--	--	1.20
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-1.03	-3.82	-4.70	-8.34	-12.86	-8.23
Free Cash Flow per Share ($)	-1.04	-3.87	-4.99	-8.75	-13.74	-8.47

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	-44.40	638.22	148.03	193.15	-2,323.37	8,066.55
ROE (%)	-57.28	-678.39	76.60	83.11	286.51	292.34
ROA (%)	-30.31	76.18	-48.69	-51.23	-50.25	-48.09
EBIT Margin (%)	--	-2,068.49	-1,276.26	-756.33	-2,368.06	-1,634.77
Net Margin (%)	-1,580.18	2,696.50	-1,245.53	-433.76	-919.20	668.59
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-0.63	-0.37	-0.48	1.37	0.06	-0.73
EBIT Growth (%)	--	-1.86	12.20	24.43	-54.15	7.88
Net Profit Growth (%)	-121.54	236.06	13.08	24.16	-12.92	8.46
EPS Growth (%)	-1.09	2.17	0.37	0.35	0.00	0.34
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	-1.22	0.35	-0.10	-0.14	-0.16	-0.17
Price / Book Value	0.89	0.77	-0.10	-0.10	-0.20	1.92
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.19	-0.38	0.95	0.31	0.54	2.47
Close Price ($)	0.74	2.26	11.20	24.80	42.20	46.20
High Price ($)	2.78	13.00	58.80	42.80	81.80	101.00
Low Price ($)	0.43	1.76	9.20	14.03	32.80	33.00
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.48	-0.52	-0.46	-0.72	2.82
Short term debt to equity ratio	--	0.34	-0.27	-0.18	-0.14	2.02
Current Ratio	2.56	1.78	3.00	2.66	5.27	6.78
Quick Ratio	--	1.70	2.94	2.56	5.02	6.73
Interest Coverage	--	-31.77	-15.70	-12.39	-45.25	-2.80

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	17.45	5.68	11.72	22.72	18.64
Asset Turnover	0.02	0.03	0.04	0.07	0.02	0.02
Receivable days	173.37	48.36	51.52	38.95	73.48	164.20
Inventory Days	--	161.34	133.19	148.99	111.33	83.14
Payable days	--	293.29	236.40	134.94	101.70	160.49
Cash Conversion Cycle	--	-83.58	-51.69	52.99	83.11	86.85